Cowen Healthcare Investments

Cowen Healthcare Investments

Cowen Healthcare Investments

FinSMEs

Pfizer Acquires Clinical-Stage Biotech Company Therachon, for Up To $810M

$67,000,000 Venture capital (Series A)
FinSMEs

Inozyme Pharma Raises $67M in Series A2 Financing

$40,000,000 Venture capital (Series B)
FinSMEs , PE Hub

Cadent Therapeutics Secures $40M Series B Financing

$80,000,000 Venture capital (Series C)
FinSMEs , PE Hub

KSQ Therapeutics Secures $80M Financing Round

Health Funding
£35,500,000 Venture capital (Series B)
FinSMEs , PE Hub

Evox Therapeutics Closes £35.5M Series B Financing

Funding Health
$60,000,000 Venture capital (Series B)
FinSMEs

Biotech Company Therachon Raises $60M Mezzanine Financing

Funding Health
$62,000,000 Venture capital (Series B)
FinSMEs , PE Hub

Pliant Therapeutics Raises $62M in Series B Financing

Funding Health
$127,500,000 Venture capital (Series A)
FinSMEs , PE Hub

Compass Therapeutics Completes $132M Series A Financing

Funding Health Science
$5,000,000 Venture capital (Series A)
Therachon

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

$35,000,000 Venture capital (Series A)
businesswire

Therachon Secures $35 Million Financing | Business Wire